Literature DB >> 27667734

Chikungunya fever: an emerging viral infection threatening North America and Europe.

Marc Z Handler1, Nancy S Handler2, Matthew P Stephany2, Glenn A Handler1, Robert A Schwartz1.   

Abstract

Since the beginning of the twenty-first century, there has been a rapid rise in the number of cases of chikungunya. Initially limited to islands of the southwestern Indian Ocean, the virus has spread across Africa and into the islands of the Caribbean. Cutaneous symptoms include a morbilliform eruption, hyperpigmented macules, and aphthae-like ulcers. Patients often also experience fever and joint pain. We review the methods for diagnosis, treatment, and prevention of this increasingly prevalent virus now emerging more commonly in Europe and North America.
© 2016 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2016        PMID: 27667734     DOI: 10.1111/ijd.13439

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  3 in total

1.  Sindbis Virus Infection Causes Cell Death by nsP2-Induced Transcriptional Shutoff or by nsP3-Dependent Translational Shutoff.

Authors:  Ivan Akhrymuk; Ilya Frolov; Elena I Frolova
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

2.  Guillain-Barre syndrome complicating chikungunya virus infection.

Authors:  Ayush Agarwal; Deepti Vibha; Achal Kumar Srivastava; Garima Shukla; Kameshwar Prasad
Journal:  J Neurovirol       Date:  2017-02-13       Impact factor: 3.739

3.  A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.

Authors:  Pedro M Folegatti; Kate Harrison; Lorena Preciado-Llanes; Fernando Ramos Lopez; Mustapha Bittaye; Young Chan Kim; Amy Flaxman; Duncan Bellamy; Rebecca Makinson; Jonathan Sheridan; Sasha R Azar; Rafael Kroon Campos; Mark Tilley; Nguyen Tran; Daniel Jenkin; Ian Poulton; Alison Lawrie; Rachel Roberts; Eleanor Berrie; Shannan L Rossi; Adrian Hill; Katie J Ewer; Arturo Reyes-Sandoval
Journal:  Nat Commun       Date:  2021-07-30       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.